Radiolabeling of dextran with rhenium-188

Applied Radiation and Isotopes

Volumn 53, Issue 3, 2000, Pages 443-448

  Du, Jin ^a   Marquez, Marcela ^b   Hiltunen, Jukka ^a   Nilsson, Sten ^b   Holmberg, Anders R ^a,b  

^a MAP Medical Technologies Oy   (Finland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

188Re; Radiolabeling; Thiol dextran; Transchelation

Indexed keywords

ALDEHYDES; BLOOD SUBSTITUTES; CHELATION; DIAGNOSIS; NUCLEAR MEDICINE; OXIDATION; POLYSACCHARIDES; RADIOTHERAPY; RHENIUM;

CYSTEINE; DEXTRAN; RADIOLABELING; SODIUM PERIODATE; TRANSCHELATION;

RADIOISOTOPES;

DEXTRAN; RHENIUM 188;

ARTICLE; COMPLEX FORMATION; DRUG STABILITY; IN VITRO STUDY; ISOTOPE LABELING; PRIORITY JOURNAL; REACTION ANALYSIS; TECHNIQUE;

DEXTRANS; INDICATORS AND REAGENTS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RHENIUM;

EID: 0034666810     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(99)00283-3     Document Type: Article

References (28)

1. Andersson A., Holmberg A., Carlsson J., Carlsson J., Ponten J., Westermark B. Binding of epidermal growth factor-dextran conjugates to cultured glioma cells. Int. J. Cancer. 47:1991;439-444.
2. Bernstein A., Hurwitz E., Maron R., Arnon R., Sela M., Wilchek M. Higher antitumor efficacy of daunomycin when linked to dextran: in vivo and in vitro studies. J. Natl. Cancer Inst. 60:1978;379-384.
3. Callahan A.P., Rice D.E., Knapp F.F. Jr. Rhenium-188 for therapeutic applications from an alumina based tungsten-188/rhenium-188 radionuclide generator. NucCompact-Eur/Am. Commun. Nucl. Med. 20:1989;3-6.
4. De Kievet W. Technetium radiopharmaceutical: chemical characterization and tissue distribution of Tc-glucoheptonate using Tc-99m and carrier Tc-99. J. Nucl. Med. 22:1981;703-709.
5. DeBelder A.N. Dextran. 2nd ed :1990;Pharmacia Print, Uppsala, Sweden.
6. Deutsch E., Lisbon K., Vanderheyden J.L., Ketring A.R., Maxon H.R. The chemistry of rhenium and technetium as related to the use of isotopes of the elements in therapeutic and diagnostic nuclear medicine. Nucl. Med. Biol. 13:1986;465-477.
7. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:1959;70-77.
8. 99mTc as a lymphoscintigraphic agent in rabbits. Eur. J. Nucl. Med. 11:1982;80-84.
9. Fassio E., Terg R., Landerira G., Abecasis R., Salemne M., Podesta A., Rodriguez P., Levi D., Kravetz D. Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites, results of randomized study. J. Hepatolxy. 14:1992;310-316.
10. Guhlke S., Zamora P.O., Sartor J., Knapp F.F. Jr., Bender H., Rhodes B.A., Biersack H.J. Ascorbic acid stabilization of Re-188 and I-131 radiolabeled peptides for radiotherapy. Radiochimica Acta. 79:1997;93-97.
11. 186,188Re for nuclear medicine. Top. Curr. Chem. 176:1996;275-291.
12. Henze E., Robinson G.D., Kuhl D.E., Schelbert H.R. Tc-99m Dextran: a new blood-pool-labeling agent for radionuclide angiocardiography. J. Nucl. Med. 23:1982;348-353.
13. 99mTc labeled to antibodies? Nucl. Med. Biol. 21:1994;1035-1044.
14. Holmberg A, Meurling L. Preparation of sulfhydrylborane-dextran conjugates for boron neutron capture therapy. Bioconj. Chem. 4:1993;570-573.
15. 99mTc. Antibody Immunoconj. Radiopharm. 7:1994;149-154.
16. Holmberg A., Marquez M., Westlin J.-E., Nilsson S. Preparation, in vitro binding and technetium-99m labeling of somatostatin-dextran conjugatesxy. Antibody Immunoconj. Radiopharm. 7:1994;253-259.
17. Holmberg, A., Wilchek, M., Marquez, M., Westlin, J.-E., Du, J., Nilsson, S. Ion exchange tumor targeting, a new approach. Clin. Cancer Res. (in press).
18. Hurwitz E. Specific and nonspecific macromolecule-drug conjugates for the improvement of cancer chemotherapy. Biopolym. 22:1983;557-567.
19. Juweid M., Sharkey R.M., Swayne L.C., Griffiths G.L., Dunn R., Goldenberg D.M. Pharmacokinetics, dosimetry and toxicity of rhenium-188 labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. J. Nucl. Med. 49:1998;34-42.
20. 188Re generator for biomedical applications. Radiochimica Acta. 65:1994;39-46.
21. 99mTc-Dextran. Nucl. Med. Comm. 9:1988;662-662.
22. Knapp F.F. Jr., Beets A.L., Guhlke S., Zamora P.O., Bender H., Palmedo H., Biersack H.J. Availability of rhenium-188 from alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceutical for cancer treatment. Anticancer Res. 17:1997;1783-1796.
23. Moon P.F., Snyder J.R., Haskins S.C., Perron P.R., Kramer G.C. Effects of highly concentrated hypertonic saline-dextran volume expander on cardiopulmonary function in anesthetized normovolemic horses. Am. J. Vet. Res. 52:1991;1611-1618.
24. Noguchi A., Takahashi T., Yamaguchi T., Kitamura K., Takakura Y., Hashida M., Sezaki H. Preparation and properties of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate. Bioconj. Chem. 3:1992;132-137.
25. Omori T. Substitution reactions of technetium compounds. Top. Curr. Chem. 176:1996;253-273.
26. Rhodes B.A., Lambert C.R., Marek M.J., Knapp F.F. Jr., Harvey E.B. Re-188 labeled antibodies. Appl. Radiat. Isot. 47:1996;7-14.
27. Rowland G.F. Effective antitumour conjugates of alkylating drug and antibody using dextran as the intermediate carrier. Eur. J. Cancer. 13:1977;593-596.
28. 99mTc-dextran for lymphoscintigraphy. Eur. J. Nucl. Med. 15:1989;146-151.